The Nasdaq shows signs of uncertainty, with price action indicating a potential slowdown amid trade war concerns. See why I ...

GE HealthCare Technologies, spun off from General Electric in 2023, has shown significant stock growth. See why I rate GEHC ...

Palantir's key contracts like the Army Vantage extension and TITAN system will benefit the tech giant for some time. Read ...

Zscaler’s recent earnings are solid, but growth deceleration continues. Read why ZS stock’s bullish technicals and weak ...

The US stock market outperforms due to superior economic production factors: capital, technology, and labor, making it ideal ...

Analyst evaluates Nutanix's growth prospects, cost pressures, and stock valuation in light of earnings growth and industry ...

Medical device specialist DexCom (NASDAQ: DXCM) has substantially underperformed the market over the trailing-12-month period ...

Medpace demonstrates strong financial performance and growth in the CRO market, despite facing challenges in the short term. Read why MEDP stock is a Strong Buy.

Lam Research's Q2-2025 earnings beat expectations, with strong revenue and EPS growth. Read why I remain neutral on LRCX ...

LENSAR, Inc.'s ALLY Robotic Cataract Laser System has driven significant revenue and earnings growth. Read why LNSR stock is ...

Alphabet's recent revenue miss caused a stock drop, but strong growth in core segments like Google Cloud makes it a ...